Advertising and Promotion Considerations for Biologics, Biosimilars, and Interchangeables | Morgan Lewis - As Prescribed

FDA recently issued a revised draft guidance titled Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and...

Related Keywords

,Product Communications That Are Consistent ,Public Health Service Act ,Advertising Considerations ,Prescription Biological Reference Products ,Biosimilar Products ,Interchangeable Biosimilar ,Product Communications That Are Consistent With ,Required Labeling ,